A Study of Immunotherapy Combined With Neoadjuvant Therapy Versus Neoadjuvant Therapy for Breast Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This is a randomized, open label Phase II neoadjuvant study comparing the efficacy and safety of the combination of traditional herbal medicine for cancer immunotherapy and neoadjuvant therapy versus neoadjuvant therapy in patients with breast cancer.
Epistemonikos ID: 5b69e0c864bc7fa06879ba167a2992fc626903fa
First added on: May 13, 2024